Daniel Shin is a venture capitalist and senior luxury fashion executive, overseeing corporate development at MCM, a German luxury brand.
Medical misinformation: Why science must stand above politics and profit

Daniel Shin
Evidence-based science exists to determine what is true, not what is politically legitimate or commercial-driven. When scientific findings are shaped by political agendas or financial incentives, the consequences extend far beyond academic debate. In health and medicine, misinformation can directly cost lives. In this environment, prudent medical journalism, which must be addressed in a timely and accessible way, can be lifesaving.
The COVID-19 pandemic made this danger unmistakable. In several countries, scientific guidance on prevention and treatment became deeply politicized. Some promoted unproven or disproven treatments such as hydroxychloroquine and ivermectin, while certain politicians cast doubt on evidence-based measures including vaccines, masking and social distancing. These mixed messages undermined public trust and blurred the line between medical evidence and political assertion during a global health crisis.
During the pandemic, vaccine acceptance was tied to partisan identity rather than scientific evidence. Later studies showed significantly higher COVID-19 mortality rates in regions with lower vaccination uptake, which was often tied to political affiliation. Hospitals reported patients delaying effective treatment while relying on misinformation promoted by politically affiliated media outlets and influencers. These outcomes demonstrate how distorted information can translate directly into preventable illness and death.
A similar pattern is being witnessed around GLP-1 weight loss drugs. Social media often presents these medications as producing effortless weight loss with no risk, while other narratives exaggerate dangers.
There are known issues, including gastrointestinal side effects, like nausea or vomiting. Weight rebound can be triggered from stopping drugs without formidable lifestyle changes. While there are ongoing debates and lawsuits alleging inadequate warnings, medical misinformation amplifies both benefits and harms. When heavy promotion on social media and click-driven content distribution prioritize profit over evidence, patients are often left vulnerable to fears, false hopes and impulsive purchases from unverified sources.
The harm of medical misformation is often most severe in underserved and rural communities where healthcare access is limited and reliable information sources are scarce. In these settings, political rhetoric and misinformation often replace valuable onsite medical advice, potentially leading to increases in hospitalizations and fatalities. When science is politicized or monetized, those with the least resources bear the greatest impact.
There should be no politics or profit-driven manipulation in evidence-based science. Science is grounded in empirical validation and peer review, while political and commercial systems are often driven by competition and monetary outcomes. When profit motives override patient safety, evidence may be selectively presented, risks downplayed or benefits exaggerated to protect promising commercial opportunities. This not only erodes public trust but places lives at risk. In medicine, financial success must never come at the expense of transparency, safety or informed consent.
When misinformation meets inequity, it deepens existing disparities. Health misinformation is also uniquely dangerous because people act on what they believe. False claims about vaccines, treatments or disease prevention can lead to delayed care, harmful self-medication, overdoses or rejection of effective therapies. These dangers are intensified in communities with limited access to healthcare, lower health literacy or historical mistrust of institutions.
This is why prudent medical journalism is essential. In a media landscape shaped by algorithms, advertising revenue and "attention economics," simply relaying official statements or marketing claims is insufficient. Prudent medical journalism critically examines data, questions sources, exposes conflicts of interest and places patient welfare above political or commercial pressure. It translates complex scientific findings into clear and contextualized information that people can easily use to make informed decisions.
Discoverability is equally important. Even the most accurate reporting fails if it cannot reach those who need it most. This requires plain language, multilingual formats, visuals and culturally relevant stories, delivered through the platforms people already use, without sacrificing rigor or independence.
Ultimately, protecting science from political distortion, resisting profit-driven misinformation and strengthening prudent medical journalism are inseparable responsibilities. A society that values human life must ensure that truth, not political aspiration or profit, guides medical communication as many lives depend on it.
Daniel Shin is a venture capitalist and senior luxury fashion executive. He also teaches at various higher education institutions.